Literature DB >> 11526537

A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver.

B Akhurst1, E J Croager, C A Farley-Roche, J K Ong, M L Dumble, B Knight, G C Yeoh.   

Abstract

Several reliable and reproducible methods are available to induce oval cells in rat liver. Effective methods often involve inhibiting proliferation in hepatocytes using an alkylating agent, then subjecting the rat to partial hepatectomy (PH). The surgery is difficult to perform reproducibly in mice. Approaches that do not include partial hepatectomy, such as administration of D-galactosamine, are ineffective in mice. We found that a choline-deficient, ethionine-supplemented (CDE) diet, which is very effective in rats, leads to high morbidity and mortality when administered to mice. This article outlines an alternative protocol by which a CDE diet can be administered to mice. This diet is shown to be highly effective for oval cell induction, without causing high mortality. It takes less time and is at least as effective as other commonly used protocols for inducing oval cells in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526537     DOI: 10.1053/jhep.2001.26751

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  73 in total

1.  Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.

Authors:  Joan Font-Burgada; Shabnam Shalapour; Suvasini Ramaswamy; Brian Hsueh; David Rossell; Atsushi Umemura; Koji Taniguchi; Hayato Nakagawa; Mark A Valasek; Li Ye; Janel L Kopp; Maike Sander; Hannah Carter; Karl Deisseroth; Inder M Verma; Michael Karin
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

Review 2.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

Review 3.  Cellular homeostasis and repair in the mammalian liver.

Authors:  Ben Z Stanger
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 4.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

Review 5.  beta-cell Regeneration: neogenesis, replication or both?

Authors:  Fred Levine; Pamela Itkin-Ansari
Journal:  J Mol Med (Berl)       Date:  2007-10-06       Impact factor: 4.599

6.  FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration.

Authors:  Hinako M Takase; Tohru Itoh; Seitaro Ino; Ting Wang; Takehiko Koji; Shizuo Akira; Yasuhiro Takikawa; Atsushi Miyajima
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

7.  HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Authors:  Bilon Khambu; Nazmul Huda; Xiaoyun Chen; Daniel J Antoine; Yong Li; Guoli Dai; Ulrike A Köhler; Wei-Xing Zong; Satoshi Waguri; Sabine Werner; Tim D Oury; Zheng Dong; Xiao-Ming Yin
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice.

Authors:  M Vorobeychik; K Bloch; R Zemel; L Bachmetov; R Tur-Kaspa; P Vardi
Journal:  J Mol Histol       Date:  2008-07-31       Impact factor: 2.611

Review 9.  Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

Authors:  David A Shafritz; Michael Oertel
Journal:  Int J Biochem Cell Biol       Date:  2010-01-18       Impact factor: 5.085

10.  Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats.

Authors:  Shafina Hanim Mohd Habib; Suzana Makpol; Noor Aini Abdul Hamid; Srijit Das; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.